These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7944941)

  • 1. Preoperative evaluation of abnormal mammographic findings to avoid unnecessary breast biopsies.
    Morrow M; Schmidt R; Cregger B; Hassett C; Cox S
    Arch Surg; 1994 Oct; 129(10):1091-6. PubMed ID: 7944941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The abnormal mammogram in women with clinically normal breasts.
    Sterns EE
    Can J Surg; 1995 Apr; 38(2):168-72. PubMed ID: 7728672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic breast biopsy as an alternative to open excisional biopsy.
    Cross MJ; Evans WP; Peters GN; Cheek JH; Jones RC; Krakos P
    Ann Surg Oncol; 1995 May; 2(3):195-200. PubMed ID: 7641014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of core-needle breast biopsy on the surgical management of mammographic abnormalities.
    White RR; Halperin TJ; Olson JA; Soo MS; Bentley RC; Seigler HF
    Ann Surg; 2001 Jun; 233(6):769-77. PubMed ID: 11371735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic core needle breast biopsy is an accurate diagnostic technique to assess nonpalpable mammographic abnormalities.
    Fuhrman G; Cederbom G; Champagne J; Farr G; McKinnon W; Bolton J; Ordoyne WK
    J La State Med Soc; 1996 Apr; 148(4):167-70. PubMed ID: 8935619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening mammography: value in women 35-39 years old.
    Liberman L; Dershaw DD; Deutch BM; Thaler HT; Lippin BS
    AJR Am J Roentgenol; 1993 Jul; 161(1):53-6. PubMed ID: 8517320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening mammography: a surgeon's strategy for dealing with abnormal mammographic findings.
    Muskett A; McGreevy JM
    Am J Surg; 1987 Dec; 154(6):589-92. PubMed ID: 3425799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term follow-up results in 795 nonpalpable probably benign lesions detected at screening mammography.
    Vizcaíno I; Gadea L; Andreo L; Salas D; Ruiz-Perales F; Cuevas D; Herranz C; Bueno F;
    Radiology; 2001 May; 219(2):475-83. PubMed ID: 11323475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up.
    Mahoney MC; Robinson-Smith TM; Shaughnessy EA
    AJR Am J Roentgenol; 2006 Oct; 187(4):949-54. PubMed ID: 16985141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic core biopsy of the breast: results of one-year follow-up of 101 patients.
    Pitre B; Baron PL; Baron LF; O'Brien PH; Cole DJ
    Am Surg; 1997 Dec; 63(12):1124-7. PubMed ID: 9393264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic core-needle breast biopsy by surgeons: minimum 2-year follow-up of benign lesions.
    Burns RP; Brown JP; Roe SM; Sprouse LR; Yancey AE; Witherspoon LE
    Ann Surg; 2000 Oct; 232(4):542-8. PubMed ID: 10998652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of stereotactic breast biopsy in mammographically suspicious lesions].
    Jäger HJ; Schatz TH; Mehring UM; Kubasch M; Hennigs S; Gissler HM; Spörl HD; Mathias KD
    Rofo; 2000 Apr; 172(4):346-53. PubMed ID: 10961219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing emphasis in breast diagnosis: the surgeon's role in evaluating mammographic abnormalities.
    Sterns EE
    J Am Coll Surg; 1997 Mar; 184(3):297-302. PubMed ID: 9060928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Happens after a Diagnosis of High-Risk Breast Lesion at Stereotactic Vacuum-assisted Biopsy? An Observational Study of Postdiagnosis Management and Imaging Adherence.
    Gao Y; Albert M; Young Lin LL; Lewin AA; Babb JS; Heller SL; Moy L
    Radiology; 2018 May; 287(2):423-431. PubMed ID: 29378151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic breast biopsy: a six-year surgical experience.
    Tate PS; Rogers EL; McGee EM; Page GV; Hopkins SF; Shearer RG; Harris JM; Johnson RC; Dubilier LD; Bensema MH; Jansen JF; Clark TD
    J Ky Med Assoc; 2001 Mar; 99(3):98-103. PubMed ID: 11268786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal mammographic findings. A critical appraisal.
    Carter PL; Gillespie JT
    Am J Surg; 1984 May; 147(5):638-40. PubMed ID: 6721040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open versus stereotactic breast biopsy.
    Frazee RC; Roberts JW; Symmonds RE; Snyder SK; Hendricks JC; Smith RW; Harrison JB
    Am J Surg; 1996 Nov; 172(5):491-3; discussion 494-5. PubMed ID: 8942551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of the value of negative sonographic and mammographic findings in patients with palpable abnormalities of the breast.
    Shetty MK; Shah YP
    J Ultrasound Med; 2002 Nov; 21(11):1211-6; quiz 1217-9. PubMed ID: 12418762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up of breast lesions diagnosed as benign with stereotactic core-needle biopsy: frequency of mammographic change and false-negative rate.
    Lee CH; Philpotts LE; Horvath LJ; Tocino I
    Radiology; 1999 Jul; 212(1):189-94. PubMed ID: 10405741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial experience with the advanced breast biopsy instrumentation system.
    Matthews BD; Williams GB
    Am J Surg; 1999 Feb; 177(2):97-101. PubMed ID: 10204548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.